Vaidya, P., Chow, W. A. (2026). Phase 2 study of metronomic cyclophosphamide with pembrolizumab in checkpoint inhibitor–refractory melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9599